ERO1A and colorectal cancer: We established the ERO1α KO colorectal cancer cell lines by using the CRISPR/Cas9 system; among the genetic-modification techniques that trigger non-homologous end joining, the CRISPR/Cas9 system is more specific than the methods employing zinc finger nucleases or transcription activator-like effector nucleases.